0001209191-22-049493.txt : 20220912
0001209191-22-049493.hdr.sgml : 20220912
20220912161013
ACCESSION NUMBER: 0001209191-22-049493
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220908
FILED AS OF DATE: 20220912
DATE AS OF CHANGE: 20220912
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kornitzer Benjamin
CENTRAL INDEX KEY: 0001855842
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40332
FILM NUMBER: 221238663
MAIL ADDRESS:
STREET 1: C/O AGILON HEALTH, INC.
STREET 2: 6210 E HWY 290, SUITE 450
CITY: AUSTIN
STATE: TX
ZIP: 78723
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: agilon health, inc.
CENTRAL INDEX KEY: 0001831097
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
IRS NUMBER: 371915147
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6210 E HWY 290
STREET 2: SUITE 450
CITY: AUSTIN
STATE: TX
ZIP: 78723
BUSINESS PHONE: 562-256-3800
MAIL ADDRESS:
STREET 1: 6210 E HWY 290
STREET 2: SUITE 450
CITY: AUSTIN
STATE: TX
ZIP: 78723
FORMER COMPANY:
FORMER CONFORMED NAME: Agilon Health Topco, Inc.
DATE OF NAME CHANGE: 20201103
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-09-08
0
0001831097
agilon health, inc.
AGL
0001855842
Kornitzer Benjamin
C/O AGILON HEALTH, INC.
6210 E HWY 290, SUITE 450
AUSTIN
TX
78723
0
1
0
0
Chief Med. & Quality Officer
Common Stock
2022-09-08
4
M
0
13490
4.49
A
24343
D
Common Stock
2022-09-08
4
S
0
10546
22.558
D
13797
D
Common Stock
2022-09-08
4
S
0
2944
23.0229
D
10853
D
Common Stock
2022-09-09
4
M
0
8094
4.49
A
18947
D
Common Stock
2022-09-09
4
S
0
8094
23.0777
D
10853
D
Options (Rights to Buy)
4.49
2022-09-08
4
M
0
13490
0.00
D
2030-01-31
Common Stock
13490
368551
D
Options (Rights to Buy)
4.49
2022-09-09
4
M
0
8094
0.00
D
2030-01-31
Common Stock
8094
360457
D
Includes restricted stock units.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $22.015 to $23.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $23.015 to $23.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $22.95 to $23.275, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
These options were granted on January 31, 2020 and vest in four equal installments on January 31st of each of 2021, 2022, 2023, and 2024.
/s/ Timothy Bensley, as Attorney-in-Fact
2022-09-12